5 doctors weighed in:

Can anyone tell me about a new glaucoma treatment called rock inhibitors for glaucoma?

5 doctors weighed in
Dr. Richard Lehrer
Ophthalmology
2 doctors agree

In brief: New Class of Drug

Rock inhibitors or rho-kinase inhibitors are currently under investigation for glaucoma therapy by at least 2 pharma companies.
They show promise in animal models and early phase clinical trials. They may have some unwanted side effects and probably will not be on the market for several years if they are approved by the fda.

In brief: New Class of Drug

Rock inhibitors or rho-kinase inhibitors are currently under investigation for glaucoma therapy by at least 2 pharma companies.
They show promise in animal models and early phase clinical trials. They may have some unwanted side effects and probably will not be on the market for several years if they are approved by the fda.
Dr. Richard Lehrer
Dr. Richard Lehrer
Thank
Dr. Benjamin Chun
Ophthalmology

In brief: Rho kinase

Its a new drug still under development.
Rho kinase (rock) inhibitors target cells in the trabecular meshwork to enhance aqueous humor outflow, this in turn decreases intraocular pressure, which is the goal for glaucoma treatment.

In brief: Rho kinase

Its a new drug still under development.
Rho kinase (rock) inhibitors target cells in the trabecular meshwork to enhance aqueous humor outflow, this in turn decreases intraocular pressure, which is the goal for glaucoma treatment.
Dr. Benjamin Chun
Dr. Benjamin Chun
Thank
Dr. Jon Fishburn
Ophthalmology

In brief: New medication class

Rock inhibitors ( rho-kinase inhibitors) are not fda approved yet but unique in their approach to specifically target cells in the trabecular mesh work (drain of eye) to improve aqueous outflow.
They may also manifest neuroprotection, anti inflammatory, and enhancement of optic nerve blood flow effects. Stay tuned to this most fascinating class of medications.

In brief: New medication class

Rock inhibitors ( rho-kinase inhibitors) are not fda approved yet but unique in their approach to specifically target cells in the trabecular mesh work (drain of eye) to improve aqueous outflow.
They may also manifest neuroprotection, anti inflammatory, and enhancement of optic nerve blood flow effects. Stay tuned to this most fascinating class of medications.
Dr. Jon Fishburn
Dr. Jon Fishburn
Thank
Get help from a real doctor now
Dr. Marsha Davis
Board Certified,
24 years in practice
67M people helped
Continue
108,000 doctors available
Read more answers from doctors